Related Experiment Video
Updated: Jul 15, 2026

Detecting the Lyme Disease Spirochete, Borrelia Burgdorferi, in Ticks Using Nested PCR
Published on: February 4, 2018
[Antibiotherapy for early localized Lyme disease].
G Monsel1, A Canestri, E Caumes
1Service des maladies infectieuses et tropicales, groupe hospitalier de la Pitié-Salpêtrière, Assistance publique-hôpitaux de Paris, 47-83, boulevard de l'hôpital, 75651 Paris cedex 13, France.
Effective treatments for early localized Lyme disease include amoxicillin, doxycycline, and cefuroxime axetil, offering high efficacy with minimal adverse effects. Azithromycin serves as a viable alternative for patients requiring different therapeutic options.
Area of Science:
- Infectious Diseases
- Bacteriology
- Pharmacology
Context:
- Early localized Lyme disease presents with erythema migrans and associated symptoms.
- Effective treatment is crucial to prevent the progression to late-stage complications.
- Antibiotic therapy is the cornerstone of managing early Lyme disease.
Purpose:
- To provide evidence-based guidelines for the antibiotherapy of early localized Lyme disease.
- To outline recommended treatment regimens, dosages, and durations.
- To assess the efficacy and safety profiles of various antibiotic options.
Summary:
- Amoxicillin, doxycycline, and cefuroxime axetil demonstrate equal efficacy in treating early localized Lyme disease.
- Azithromycin is a suitable alternative, with most patients achieving complete symptom resolution.
- Adverse effects are generally infrequent, with Jarisch-Herxheimer reaction noted in approximately 15% of patients.
Impact:
- Clinicians can confidently select appropriate antibiotic therapies for early Lyme disease.
- Guidelines facilitate optimal patient outcomes, including symptom clearance and prevention of late complications.
- Understanding treatment options and potential side effects aids in informed clinical decision-making.
Related Concept Videos
Diphtheria
Endocarditis III: Medical Management
Rocky Mountain Spotted Fever
Acute Pyelonephritis II: Diagnostic Studies and Management
Inhibitors of Bacterial DNA Synthesis
Antibiotic Selection

